objective of this study is to 1) describe a novel HPV-positive LSCC cell line and 2) report the prevalence of HPV-positive LSCC in a select patient population.
Head and Neck Surgery Prospective Evaluation of the McGill thyroid Nodule Score
Yalon Dolev, MD (presenter); Michael P. Hier; Michael Tamilia, MD, FRCP; Richard J. Payne, MD, FRCS Objective: 1) Familiarize the audience with the new McGill Thyroid Nodule Score (MTNS) scoring system for thyroid nodules. 2) Present the statistics on the MTNS and why we feel this is a great adjunct in the management of thyroid nodules. 3) Describe a new tool at the clinician's disposal that will help better manage patients with thyroid nodules.
Method: This is a prospective study. A total of 245 consecutive patients were enrolled between July 2009 and March 2011. McGill Thyroid Nodule Score (MTNS), age, gender, and extent of surgery were recorded preoperatively. Final pathology was recorded postthyroidectomy. The percentage of malignancy was calculated for each MTNS score. Using Fisher exact test, the risk of malignancy for each group was compared to that anticipated based on the MTNS. We then used linear regression to plot a best fit curve for both the retrospective and prospective data and compared the 2.
Results:
We found no statistically significant difference when comparing the risk of malignancy between the retrospective group originally used to create the MTNS and the prospective group used to validate this tool with P > .05 for all groups. Regression analysis revealed linear curves and also showed no significant difference between both groups (P = .35).
Conclusion:
The MTNS system has been validated prospectively and is a unified and individualized tool to help clinicians with multiple aspects in the management of patients with thyroid nodules. This includes discussion with patients regarding the risk of their nodules harbouring malignancy, decisions regarding extent of surgery, and discussion between physicians.
Head and Neck Surgery Protection of Radiotherapy-induced Xerostomia with Vitamin E+C Complex
Ki-Nam Park (presenter); Young-Ik Son, MD, PhD; Chung Hwan Baek Objective: Salivary tissues are easily damaged by radiotherapy (RT) and therefore xerostomia becomes the most common complaint in patients who receive RT in the head and neck area. This study aimed to elucidate the effective of antioxidant vitamin E and C complex on the protection of RT-induced xerostomia.
Method: A trial group received a vitamin E (200 IU) + C (500 mg) complex for 3 months of peri-RT period. A control group took placebo which had no inner contents. Subjective questionnaires, objective grading by a nurse-specialist, and scintigraphs were obtained before and after 1 and 6 months of RT.
Results: Sixty-five patients were initially enrolled and 39 patients completed the study as scheduled. There were no differences in age, sex, RT dosage, tumor staging, and treatment modality between the 2 groups. The trial group reported less discomfort in 2 items of subjective evaluation; "impaired speech" and "difficulty of mastication" (P < .05). Pre-and poststimulatory oral salivary scan were higher in the trial group (P < .034 and P < .026, respectively). In the trial group, maximum accumulations in submandibular gland were significantly higher at 1 month as well as at 6 months after RT (P < .041 and P < .004, respectively).
Conclusion: Short-term administration of antioxidant vitamin E and C complex during the period of RT has protective roles against xerostomia. Higher oral activity in the trial (vitamin E+C) group is probably based on the protection of accumulatory function of the SMG. Results: Preliminary results demonstrate lower QOL scores among Ghanaian patients undergoing treatment compared with healthy controls (94.5 vs 111). Patients undergoing treatment also have lower scores for physical well-being (22.5 vs 26.4), functional well-being (14 vs 18.5), and head and neck-specific symptoms (20.5 vs 36.4). Ghanaians undergoing treatment had higher scores for emotional well-being compared with healthy Ghanaians (22 vs 16.1). Initial comparison of the Ghanaian and American treatment groups revealed similar scores for physical well-being (22.5 vs 18.9) and functional impairment (14 vs 15.3). However, the Ghanaian patients had higher scores for emotional well-being (22 vs 16.8).
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Conclusion: QOL of Ghanaian head and neck cancer patients is significantly worse than healthy controls. Patients are most affected by physical and functional impairments. Emotional well-being is not worse for Ghanaians undergoing treatment. Ghanaian patients are similar to Americans in physical and functional well-being. However, Ghanaian patients demonstrate greater sense of emotional well-being.
Head and Neck Surgery Quality-of-Life tools in Oral and Oropharyngeal Cancer
Sami P. Moubayed, MD (presenter); John S. Sampalis; Apostolos Christopoulos, MD Objective: 1) To identify and evaluate patient-reported quality of life (QOL) questionnaires used in studies of oral and oropharyngeal cancer. 2) To provide information on the trends of use of each questionnaire according to language, country of origin, publication date, and type of treatment.
Method: Systematic review of the English-language literature. A search using the Medical Subject Headings (MeSH) queries ("Oropharyngeal Neoplasms" OR "Mouth Neoplasms") AND "Quality of Life" was carried out by using a publicly available MEDLINE interface (PubMed). A total of 371 articles were identified and reviewed. We identified all English-language studies of oral or oropharyngeal cancer patients that measure QOL using a patient-reported questionnaire. Exclusion criteria are review article, comment, non-English-language study, wrong disease, and absence of quality of life measure.
Results: Identified questionnaires will be summarized. Each instrument will be compared against the standards for health outcome instrument development and evaluation of the Scientific Advisory Committee of the Medical Outcomes Trust.Descriptive statistics regarding identified studies will be presented regarding questionnaire use by language, country of origin, publication date, and type of treatment.
Conclusion:
Our results will help identify well-researched areas in patient-reported measures of QOL, and areas where more research is required. This is also the first study to objectively measure the number of studies that use each patient-reported QOL questionnaire according to language, country of origin, publication date, and type of treatment. Such data is crucial in helping adequate questionnaire selection for evaluation of QOL. Results: Out of 23 cases, 17 were rare malignancies of the parapharyngeal space. Of these, 6 tumors arose de novo (sarcoma, squamous cell carcinoma, synovial sarcoma, fibrosarcoma, rhabdomyosarcoma, and leiomyosarcoma) and 3 were direct extension of deep lobe parotid tumor (undifferentiated carcinoma with neck metastasis). Other rare tumors were extra osseous chordoma of the parapharyngeal space (n = 1), malignant fibrous histiocytoma (n = 1), malignant ameloblastoma (n = 1), malignant melanoma extending to the infratemporal fossa (n = 1), malignant schwannoma (n = 1), malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation (triton tumor; n = 1), neurofibroma with atypia (n = 1), and extraosseus Ewing's sarcoma (n = 1). Fourteen out of 23 (60.8%) patients are alive with no evidence of disease on variable follow up with mean follow up of 15 months.
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Conclusion: Tumors of the parapharyngeal space are uncommon, comprising less than 1% of all head and neck neoplasms. Accurate diagnosis and management is challenging and requires a team approach. When the diagnosis is ambiguous, a complete surgical excision and histopathological examination should be the preferred approach for these rare tumors.
